DSIP
Also known as: Delta Sleep-Inducing Peptide, Emideltide
Delta sleep-inducing nonapeptide taken for sleep quality, dosed a few hours before bed on an empty stomach. Effect is inconsistent (human replication has largely failed) and the therapeutic window is narrow, so higher doses can backfire.
Pharmacokinetics
Research only · no verified human PK. The values below are class estimates, not measured data, and this peptide is excluded from the Lab serum-level simulator.
- Half-life
- 8 min
- Time to peak
- 15 min
- Bioavailability
- 80%
- Onset
- 2.17 hours
- Dosing interval
- 24h
Administration
- Primary routes
- SubQ
- Category
- Sleep & Circadian
Safety Flags
- High immunogenicity
- Contraindicated in cancer history
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 1 outcome protocol
Simulate DSIP
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.